ZIFTOMENIB Pharmacologic Class Indexing

Class set ID
d90c719b-d24f-4a82-bdf4-2da2cfe7f01a
Version
1
Effective date
20260227
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use KOMZIFTI safely and effectively. See full prescribing information for KOMZIFTI. KOMZIFTI TM (ziftomenib) capsules, for oral use Initial U.S. Approval: 2025Kura Oncology, Inc. | Changzhou SynTheAll Pharmaceutical Co., Ltd | PharmaBlock Pharmaceuticals (ZheJiang) Co., Ltd | Revin Labs Private Limited | TCG Greenchem Manufacturing Private Limited202512091